Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gavi

- PMLiVE

Novavax gets $1.6bn from US government for coronavirus vaccine

Latest company to join Operation Warp Speed

- PMLiVE

Moderna clashes with US scientists over pivotal COVID-19 vaccine trials

Delays allegedly resulting from a lack of cooperation

- PMLiVE

GSK signs deal with Medicago for COVID-19 vaccine

Collaboration will utilise GSK’s pandemic adjuvant platform

- PMLiVE

Mesoblast expands compassionate use COVID-19 programme

Will now include children with multisystem inflammatory syndrome

- PMLiVE

Regeneron’s COVID-19 antibody cocktail enters phase 3 trial

Drug will be evaluated in preventative trial testing uninfected participants

- PMLiVE

Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK

Alleged deal could include agreement for 60 million doses

- PMLiVE

WHO takes stock of global COVID-19 R&D progress

Researchers and developers meet virtually to discuss progress

- PMLiVE

NHS test and trace system ‘still not good enough’ says health leader

Test and trace system falls short in latest figures

- PMLiVE

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

Study will evaluate experimental anti-inflammatory drug

- PMLiVE

Pfizer jumps on early data from BioNTech-partnered COVID-19 vaccine study

Preliminary data demonstrates promising immunogenicity

- PMLiVE

Innovation in the time of coronavirus

The Distancer is a simple, handheld device that aims to help ensure the safety of key workers

- PMLiVE

New study identifies drugs that are safe to use in COVID-19 treatment

Researchers find no evidence for or against the use of drugs like ibuprofen

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links